Abstract
With the current clinical method for the treatment of hypothyroidism the target for the optimum individual values for free thyroxine concentrations [FT4] and thyrotropine concentrations [TSH] of the specific patient are unknown. This situation leads to unnecessary long experimental medication administration that can take a period of sometimes one year. In this article a method will be described where hypothyroid patients are characterized with weekly measured FT4 and TSH concentrations during the first three weeks of synthetic thyroxine or levothyroxine (L-T4) treatment to predict their optimum [FT4] and belonging [TSH] endpoint for a euthyroid homeostatic state. The treatment with levothyroxine will start for all patients with a reference dose of 100 µg, which can be adjusted by the treating physician to a more safe and appropriate dose for the individual which is monitored with weekly thyroid function tests to observe the progress. After three weeks all characteristics of the patient can be inferred from the measured data. The final titration target together with the individual thyroxine half life can be calculated. With the known characteristics and the L-T4 titration target the clinician or treating physician has an instrument to reduce the experimental treatment burden for the patient from one year to a maximum of four weeks.
Similar content being viewed by others
References
Brun VH, Eriksen AH, Selseth R, Johansson K, Vik R, Davidsen B, Kaut M (2021) Hellemo L 2021 Patient-tailored levothyroxine dosage with pharmacokinetic/-pharmacodynamic modeling: a novel approach after total thyroidectomy. Thyroid 31(9):1297–1304. https://doi.org/10.1089/thy.2021.0125
Cruz-Loya M, Chu BB, Jonklaas J, Schneider DF, DiStefano J III (2022) Optimized replacement T4 and T4+T3 dosing in male and female hypothyroid patients with different bmis using a personalized mechanistic model of thyroid hormone regulation dynamics. Front. Endocrinol. 13:888429. https://doi.org/10.3389/fendo.2022.888429
Duntas LH, Jonklaas J (2019) (2019) Levothyroxine dose adjustment to optimise therapy throughout a patient’s lifetime. Adv Ther 36:S30–S46. https://doi.org/10.1007/s12325-019-01078-2
Goede SL, Leow MK, Smit JWA, Dietrich JW (2014a) A novel minimal mathematical model of the hypothalamus– pituitary–thyroid axis validated for individualized clinical applications. Math Biosci 249(2014):1–7. https://doi.org/10.1016/j.mbs.2014.01.001
Goede SL, Leow MK, Smit JWA, Klein HH, Dietrich JW (2014b) Hypothalamus-Pituitary-Thyroid Feedback Control: Implications of Mathematical Modeling and Consequences for Thyrotropin (TSH) and Free Thyroxine (FT4) Reference Ranges. Bull Math Biol. https://doi.org/10.1007/s11538-014-9955-5
Goede SL, Leow MK, (2018) Thyroid Systems Engineering, A Primer in Mathematical Modeling of the Hypothalamus-Pituitary-Thyroid Axis. River Publishers. ISBN: 978–87–93609–59–4 (Hardback) 978–87–93609–58–7 (Ebook)
Hadlow NC, Rothacker KM, Wardrop R, Brown SJ, Lim EM, Walsh JP (2013) The relationship between TSH and Free T 4 in a large population is complex and nonlinear and differs by age and sex 2013. J Clin Endocrinol Metab 98(7):2936–2943
Hoermann R, Midgley JEM, Larisch R, Dietrich JW (2019) Individualisedrequirements for optimum treatment of hypothyroidism: complex needs, limited options. Drugs in Context 8:212597. https://doi.org/10.7573/dic.212597
Johansen J, (2019) Graph 4.4.2 A graphical mathematical tool. Last updated: August 2019. Available as a free download from http://www.padowan.dk/graph/
Jonklaas J, Bianco J, Bauer AJ et al (2014) guidelines for the treatment of hypothyroidism, 2014. THYROID. https://doi.org/10.1089/thy.2014.0028
Leow MK, Goede SL (2014) The homeostatic set point of the hypothalamus-pituitary- thyroid axis - maximum curvature theory for personalized euthyroid targets. Theor Biol Med Model 11:3. https://doi.org/10.1186/1742-4682-11-35
McAninch EA, Bianco AC (2016) The history and future of treatment of hypothyroidism. Ann Intern Med 164(1):50–56. https://doi.org/10.7326/M15-1799
Midgley JEM, Toft AD, Larisch R, Dietrich JW, Hoermann R (2019) (2019) Time for a reassessment of the treatment of hypothyroidism. BMC Endocr Disord 19:37. https://doi.org/10.1186/s12902-019-0365-4
Rothacker KM, Brown SJ, Hadlow NC, Wardrop R, Walsh JP (2015) Reconciling the log-linear and non-log-linear nature of the TSH-free T4 relationship: intra-individual analysis of a large population. J Clin Endocrinol Metab. https://doi.org/10.1210/jc.2015-4011
Winter ME, (2010) Basic clinical pharmacokinetics 5th Edition. Philadelphia: WoltersKluwer/Lippincott Williams & Wilkins Health (2010) NLM ID: 101503165
Wolff TM, Dietrich JW, Müller MA (2022) Optimal hormone replacementtherapy in hypothyroidism - a model predictive control approach. Front Endocrinol 13:884018. https://doi.org/10.3389/fendo.2022.884018
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
There are no conflicts of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Goede, S.L. Fast Track Treatment of Hypothyroidism with Levothyroxine: Reaching Homeostasis within Four Weeks. Acta Biotheor 71, 10 (2023). https://doi.org/10.1007/s10441-023-09461-x
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s10441-023-09461-x